Report Code: A04311 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Penicillin is one of the most widely used antibiotic agents derived from Penicillium mold and used against several bacterial infection treatments. Their mechanism of action includes killing the bacteria by bursting their cell wall or by inhibiting their growth. Various kinds of penicillin are available to treat different kinds of infections, each one is specific for one kind of bacteria. Presently they are the most commonly used antibiotics, due to their diversity in usage against different types of bacteria. Penicillin drugs are used in the treatment of diseases such as throat infections, meningitis, and others.
Increase in prevalence of contagious diseases and rise in investments for R&D are the key factors that drive the growth of the global penicillin market. In addition, upsurge in demand for generic drugs is anticipated to fuel the market growth. However, stringent government regulations to limit the use of antibiotics and patent expiry for these antibiotic manufacturing are major factors that restrain the market growth. Moreover, rise in antimicrobial resistance of microbes and introduction of novel antibiotics with lesser side effects hamper the growth of the market. Conversely, new product development and usage of penicillin in cell cultures as a potent antibacterial agent are expected to provide potential opportunities for market expansion.
The global penicillin market is segmented on the basis of product, type, manufacturing process, mode of delivery, and end user. By product, the market is bifurcated into bulk and dosage. Based on type, it is categorized into aminopenicillin, antipseudomonal penicillin, beta-lactamase inhibitor, natural penicillin, and penicillinase-resistant penicillin. According to manufacturing process, it is divided into synthetic process, natural process, and semisynthetic process. Depending on mode of delivery, it is classified into oral, intramuscular, intravenous. As per end user, it is fragmented into hospitals, clinics, research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
Penicillin Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Type |
|
By Manufacturing Process |
|
By Mode of Delivery |
|
By End User |
|
By Region |
|
Key Market Players | Toyama Chemical Co., Ltd, Novartis AG, GlaxoSmithKline plc., Sanofi Aventis SA, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Gilead Sciences Inc., MiddleBrook Pharmaceuticals, Inc., Astellas Pharma Inc., Pfizer |
Loading Table Of Content...
Start reading.
This Report and over 71,213+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers